title: [Pacemaker, implanted cardiac defibrillator and irradiation: Management proposal in 2010 depending on the type of cardiac stimulator and prognosis and location of cancer].
abstract: Ionizing radiation may interfere with electric components of pacemakers or implantable cardioverter-defibrillators. The type, severity and extent of radiation damage to pacemakers, have previously been shown to depend on the total dose and dose rate. Over 300,000 new cancer cases are treated yearly in France, among which 60% are irradiated in the course of their disease. One among 400 of these patients has an implanted pacemaker or defibrillator. The incidence of pacemaker and implanted cardioverter defribillator increases in an ageing population. The oncologic prognosis must be weighted against the cardiologic prognosis in a multidisciplinary and transversal setting. Innovative irradiation techniques and technological sophistications of pacemakers and implantable cardioverter-defibrillators (with the introduction of more radiosensitive complementary metal-oxide-semiconductors since 1970) have potentially changed the tolerance profiles. This review of the literature studied the geometric, dosimetric and radiobiological characteristics of the radiation beams for high energy photons, stereotactic irradiation, protontherapy. Standardized protocols and radiotherapy optimization (particle, treatment fields, energy) are advisable in order to improve patient management during radiotherapy and prolonged monitoring is necessary following radiation therapy. The dose received at the pacemaker/heart should be calculated. The threshold for the cumulated dose to the pacemaker/implantable cardioverter-defibrillator (2 to 5 Gy depending on the brand), the necessity to remove/displace the device based on the dose-volume histogram on dosimetry, as well as the use of lead shielding and magnet are discussed.
authors: Service d'anesthésie réanimation, hôpital Nord, centre hospitalier universitaire de Saint-Étienne, France.
authors: P
authors: P
authors: Lambert
authors: A
authors: A
authors: Da Costa
authors: P-Y
authors: PY
authors: Marcy
authors: S
authors: S
authors: Kreps
authors: G
authors: G
authors: Angellier
authors: S
authors: S
authors: Marcié
authors: P-Y
authors: PY
authors: Bondiau
authors: C
authors: C
authors: Briand-Amoros
authors: J
authors: J
authors: Thariat
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001145:Arrhythmias, Cardiac / Q000517:prevention & control / Q000628:therapy; D017147:Defibrillators, Implantable; D020878:Device Removal; D004307:Dose-Response Relationship, Radiation; D004567:Electrodes, Implanted; D004867:Equipment Design; D004868:Equipment Failure; D005260:Female; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000532:radiotherapy*; D010138:Pacemaker, Artificial; D011835:Radiation Protection; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D012666:Semiconductors